MktsMarkets

United Therapeutics Corporation
NASDAQ: UTHRKey statistics
UTHR News
Stories mentioning UTHR from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 781,500 | 790,200 | 799,500 | 798,600 | 794,400 | 735,900 | 748,900 | 714,900 |
| Cost of Goods Sold | 133,400 | 103,400 | 100,900 | 87,600 | 92,500 | 75,900 | 83,100 | 77,800 |
| Gross Profit | 648,100 | 686,800 | 698,600 | 711,000 | 701,900 | 660,000 | 665,800 | 637,100 |
| Operating Expenses | ||||||||
| Research & Development | 138,200 | 139,500 | 127,500 | 134,000 | 149,000 | 133,800 | 103,500 | 139,600 |
| Sales General & Admin | 184,100 | 190,600 | 182,600 | 212,500 | 170,100 | 168,500 | 219,200 | 177,600 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 325,800 | 356,700 | 388,500 | 364,500 | 382,800 | 357,700 | 343,100 | 319,900 |
| Interest Income | 41,800 | 43,200 | 46,400 | 51,300 | 51,100 | 49,300 | 49,800 | 46,200 |
| Interest Expense | ||||||||
| Other Expense | (46,300) | 47,200 | 6,100 | (100.00) | (4,300) | (2,600) | 5,800 | 800.00 |
| Pretax Income | 318,300 | 444,000 | 438,000 | 408,400 | 423,500 | 396,500 | 388,600 | 355,300 |
| Tax Provision | 43,400 | 79,700 | 99,300 | 98,900 | 101,300 | 95,200 | 79,500 | 77,200 |
| Net Income (Loss) | 274,900 | 364,300 | 338,700 | 309,500 | 322,200 | 301,300 | 309,100 | 278,100 |
| Earnings Per Share (Basic) | 6.32 | 8.22 | 7.73 | 6.86 | 7.18 | 6.67 | 6.93 | 6.26 |
| Earnings Per Share (Diluted) | 5.82 | 7.61 | 7.16 | 6.41 | 6.63 | 6.21 | 6.39 | 5.85 |
| Weighted Average Shares Outstanding (Basic) | 43,500 | 44,300 | 43,800 | 45,100 | 44,900 | 45,200 | 44,600 | 44,400 |
| Weighted Average Shares Outstanding (Diluted) | 47,200 | 47,900 | 47,300 | 48,300 | 48,600 | 48,500 | 48,400 | 47,500 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About UTHR
United Therapeutics Corporation (NASDAQ: UTHR) is a stock listed on the Nasdaq Stock Market under the ticker symbol UTHR. It last traded at $577.34 (Nov 18, 2026, 4:00 PM ET), down 1.2% on the day. That gives United Therapeutics a market capitalisation of $23.9B and a price-to-earnings ratio of 19.4.
Over the past 52 weeks UTHR has traded between $455.63 and $614.23.
Revenue for the quarter ended Mar 31, 2026 was $781.5M; net income $274.9M. Revenue was down 1.6% from $794.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $781.5M | $274.9M | 35.2% |
| Dec 31, 2025 | $790.2M | $364.3M | 46.1% |
| Sep 30, 2025 | $799.5M | $338.7M | 42.4% |
| Jun 30, 2025 | $798.6M | $309.5M | 38.8% |
From United Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…